Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
07 01 2022
Historique:
received: 08 11 2019
accepted: 20 10 2020
pubmed: 3 11 2020
medline: 8 3 2022
entrez: 2 11 2020
Statut: ppublish

Résumé

Dilated cardiomyopathy (DCM) is associated with mutations in many genes encoding sarcomere proteins. Truncating mutations in the titin gene TTN are the most frequent. Proteomic and functional characterizations are required to elucidate the origin of the disease and the pathogenic mechanisms of TTN-truncating variants. We isolated myofibrils from DCM hearts carrying truncating TTN mutations and measured the Ca2+ sensitivity of force and its length dependence. Simultaneous measurement of force and adenosine triphosphate (ATP) consumption in skinned cardiomyocytes was also performed. Phosphorylation levels of troponin I (TnI) and myosin binding protein-C (MyBP-C) were manipulated using protein kinase A and λ phosphatase. mRNA sequencing was employed to overview gene expression profiles. We found that Ca2+ sensitivity of myofibrils carrying TTN mutations was significantly higher than in myofibrils from donor hearts. The length dependence of the Ca2+ sensitivity was absent in DCM myofibrils with TTN-truncating variants. No significant difference was found in the expression level of TTN mRNA between the DCM and donor groups. TTN exon usage and splicing were also similar. However, we identified down-regulation of genes encoding Z-disk proteins, while the atrial-specific regulatory myosin light chain gene, MYL7, was up-regulated in DCM patients with TTN-truncating variants. Titin-truncating mutations lead to decreased length-dependent activation and increased elasticity of myofibrils. Phosphorylation levels of TnI and MyBP-C seen in the left ventricles are essential for the length-dependent changes in Ca2+ sensitivity in healthy donors, but they are reduced in DCM patients with TTN-truncating variants. A decrease in expression of Z-disk proteins may explain the observed decrease in myofibril passive stiffness and length-dependent activation.

Identifiants

pubmed: 33135063
pii: 5949014
doi: 10.1093/cvr/cvaa316
pmc: PMC8752363
doi:

Substances chimiques

Carrier Proteins 0
Connectin 0
TTN protein, human 0
Troponin I 0
Viral Proteins 0
myosin-binding protein C 0
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
PP-lambda protein, Bacteriophage lambda EC 3.1.3.16
Phosphoprotein Phosphatases EC 3.1.3.16

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-253

Subventions

Organisme : British Heart Foundation
ID : PG/17/5/32705
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/11/20/29266
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : P01 HL062426
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

J Mol Cell Cardiol. 2009 Sep;47(3):352-8
pubmed: 19406126
J Mol Cell Cardiol. 2010 May;48(5):866-75
pubmed: 19962384
Mol Cell Proteomics. 2006 Apr;5(4):749-57
pubmed: 16340016
J Hum Genet. 2016 Jan;61(1):41-50
pubmed: 26178429
J Am Coll Cardiol. 2002 Oct 2;40(7):1267-74
pubmed: 12383574
FEBS J. 2019 Jun;286(12):2240-2260
pubmed: 30989819
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2306-11
pubmed: 26858417
J Biol Chem. 2018 Jun 1;293(22):8588-8599
pubmed: 29669813
J Mol Cell Cardiol. 2010 Dec;49(6):1003-11
pubmed: 20850451
Genome Res. 2012 Oct;22(10):2008-17
pubmed: 22722343
J Am Coll Cardiol. 2018 May 22;71(20):2293-2302
pubmed: 29773157
Proteomics. 2012 Apr;12(7):973-8
pubmed: 22522803
Biophys Rev. 2015 Dec;7(4):399-406
pubmed: 26998172
Circulation. 2018 Nov 20;138(21):2359-2366
pubmed: 30021846
J Gen Physiol. 2019 Jan 7;151(1):18-29
pubmed: 30578328
Cardiovasc Res. 2016 Oct;112(1):452-63
pubmed: 27496873
PLoS Med. 2018 Mar 27;15(3):e1002541
pubmed: 29584721
PLoS One. 2015 Sep 25;10(9):e0138568
pubmed: 26406308
JACC Heart Fail. 2015 Nov;3(11):906-16
pubmed: 26454848
Circ Res. 2015 Apr 10;116(8):1462-1476
pubmed: 25858069
Biophys Rev. 2017 Jun;9(3):225-237
pubmed: 28510118
Circulation. 2018 Nov 11;:
pubmed: 30586722
Cardiovasc Res. 2013 Jul 1;99(1):65-73
pubmed: 23539503
J Cell Biochem. 2017 Nov;118(11):3810-3824
pubmed: 28383761
J Mol Cell Cardiol. 2010 May;48(5):954-63
pubmed: 20079747
Cardiovasc Res. 2005 Jan 1;65(1):221-9
pubmed: 15621050
Sci Rep. 2017 Nov 1;7(1):14829
pubmed: 29093449
Cardiovasc Res. 2013 Sep 1;99(4):648-56
pubmed: 23764881
BMJ. 2019 Feb 13;364:l223
pubmed: 30760447
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13573-8
pubmed: 26487682
Brain. 2004 Feb;127(Pt 2):439-51
pubmed: 14711882
Biophys Rev. 2015 Mar;7(1):5-14
pubmed: 28509977
J Biol Chem. 2011 Mar 25;286(12):9935-40
pubmed: 21257760
Genome Biol. 2014;15(12):550
pubmed: 25516281
Circ Res. 2017 Sep 15;121(7):731-748
pubmed: 28912180
Sci Transl Med. 2015 Jan 14;7(270):270ra6
pubmed: 25589632
Circulation. 2002 Dec 3;106(23):2986-92
pubmed: 12460884
PLoS One. 2019 Oct 23;14(10):e0224206
pubmed: 31644553
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13307-133310
pubmed: 19622741
Circulation. 2004 Jul 13;110(2):155-62
pubmed: 15238456
Am J Pathol. 2017 Dec;187(12):2645-2658
pubmed: 28935576
Eur Heart J. 2005 Jun;26(11):1115-40
pubmed: 15901669
Circ Res. 2004 Oct 1;95(7):708-16
pubmed: 15345656
Neth Heart J. 2014 Oct;22(10):463-9
pubmed: 25200323
J Card Fail. 2017 Jun;23(6):476-479
pubmed: 28315399
J Am Coll Cardiol. 2009 Sep 1;54(10):930-41
pubmed: 19712804
Circulation. 2019 Jul 2;140(1):31-41
pubmed: 30987448
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Neuromuscul Disord. 2011 Mar;21(3):161-71
pubmed: 21256014
Sci Adv. 2019 May 22;5(5):eaav8421
pubmed: 31131323
Proteomics Clin Appl. 2009 Dec;3(12):1371-82
pubmed: 21136957
Circ Res. 1995 May;76(5):734-41
pubmed: 7728989
Biophys Rev. 2015 Dec;7(4):421-447
pubmed: 28510104
Bioinformatics. 2019 Nov 15;:
pubmed: 31730197
Front Pharmacol. 2018 Nov 27;9:1336
pubmed: 30538631
Genes (Basel). 2018 Jan 05;9(1):
pubmed: 29304022
Circ Res. 2014 Mar 14;114(6):1052-68
pubmed: 24625729
EMBO J. 1995 May 1;14(9):1952-60
pubmed: 7744002
Proc Natl Acad Sci U S A. 2016 May 24;113(21):E3039-47
pubmed: 27162358
J Muscle Res Cell Motil. 2010 Dec;31(4):289-301
pubmed: 21132354
J Biol Chem. 2018 Jun 8;293(23):9017-9029
pubmed: 29666183
MethodsX. 2016 Mar 02;3:156-70
pubmed: 27047763
Eur Heart J. 2002 Nov;23(21):1692-8
pubmed: 12398827
PLoS One. 2017 Jun 28;12(6):e0180064
pubmed: 28658286
Circulation. 2020 Feb 4;141(5):387-398
pubmed: 31983221
Nat Rev Dis Primers. 2019 May 9;5(1):32
pubmed: 31073128
Lancet. 1998 Aug;352 Suppl 1:SI8-14
pubmed: 9736474
Int J Mol Sci. 2018 Jul 31;19(8):
pubmed: 30065175
J Mol Med (Berl). 2006 Jun;84(6):446-68
pubmed: 16416311
Cardiovasc Res. 2008 Mar 1;77(4):637-48
pubmed: 17475230
N Engl J Med. 2012 Feb 16;366(7):619-28
pubmed: 22335739
Circ Res. 2009 Jan 2;104(1):87-94
pubmed: 19023132
Cardiovasc Ultrasound. 2008 Apr 21;6:15
pubmed: 18426559
J Am Coll Cardiol. 2016 Dec 27;68(25):2871-2886
pubmed: 28007147
J Physiol. 2017 Jul 15;595(14):4677-4693
pubmed: 28436080
Nat Med. 2012 May;18(5):766-73
pubmed: 22466703
J Physiol. 2007 Oct 15;584(Pt 2):591-600
pubmed: 17717017
Circulation. 2016 Dec 6;134(23):e579-e646
pubmed: 27832612
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
J Mol Cell Cardiol. 2013 Jul;60:116-20
pubmed: 23619294
J Am Heart Assoc. 2017 Jul 22;6(7):
pubmed: 28735292

Auteurs

Petr G Vikhorev (PG)

National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.

Natalia N Vikhoreva (NN)

Heart Science Centre, Magdi Yacoub Institute, Harefield Hospital, London UB9 6JH, UK.

WaiChun Yeung (W)

National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.

Amy Li (A)

Department of Pharmacy and Biomedical Sciences, La Trobe University, Bendigo, VIC 3550, Australia.

Sean Lal (S)

School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, NSW 2006, Australia.

Cristobal G Dos Remedios (CG)

Division of Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.

Cheavar A Blair (CA)

Division of Cardiovascular Medicine, Department of Physiology, University of Kentucky, Lexington, KY, USA.

Maya Guglin (M)

Division of Cardiovascular Medicine, Department of Physiology, University of Kentucky, Lexington, KY, USA.

Kenneth S Campbell (KS)

Division of Cardiovascular Medicine, Department of Physiology, University of Kentucky, Lexington, KY, USA.

Magdi H Yacoub (MH)

National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.

Pieter de Tombe (P)

National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.
Heart Science Centre, Magdi Yacoub Institute, Harefield Hospital, London UB9 6JH, UK.
Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, USA.

Steven B Marston (SB)

National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH